Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Sep 12, 2026

ARCT — Arcturus Therapeutics Holdings Inc. Dilution Risk Tracker

Track ARCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARCT — Get alerts when the score changes →

As of September 12, 2026, Arcturus Therapeutics Holdings Inc. (ARCT) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Arcturus Therapeutics Holdings Inc. has a market capitalization of $225.11M, 28.42M shares outstanding, 127 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ARCT.
🔔 Track ARCT — Get forecast alerts →

Market Data

Market Cap$225.11M
Shares Outstanding28.42M
Float26.15M
Cash$191.48M
Debt$75.66M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding28.42MVerified float table or market cache
Public Float26.15MVerified float table or market cache
Market Cap$225.11MMarket data cache
Cash Runway23.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.4% shares (2026Q1 vs prior)
127 institutional holders · 28.54M shares
#1 FEDERATED HERMES, INC. 3.30M shares
#2 ARK Investment Management LLC 2.77M shares
#3 BlackRock, Inc. 2.61M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.10M
Days to Cover3.1
% of Float23.3%
FINRA data as of Aug 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track ARCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT AATC AEHR AEMRF AGGID AGM AHRT AIJTY ALDX ALOT

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ARCT
ARCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.